Regentis Biomaterials - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRegentis Biomaterials
Regentis Biomaterials logo

Regentis Biomaterials

0 followers

RGNT

Performance

About Regentis Biomaterials

Regentis Biomaterials is a tissue repair company that develops and commercializes an innovative hydrogel platform for repairing damaged tissue. Its current focus is on orthopedic treatments using resorbable hydrogel implants to regenerate diseased or damaged tissue. The company is privately held with headquarters in Or Akiva, Israel, backed by a diverse group of investors, and adheres to high manufacturing standards including GMP and ISO 13485.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

Israel

Founded

2004

Employees

1 - 10

Status

Public

Website

https://regentis.co.il